Loss of HLA Class I tumor expression was related to a better prognosis in CRC in most studies[14,23] and HLA-E and HLA-G tumor expression has been correlated with a poor prognosis and tumor progression[24,25]. The gene discussed is HLA-G; the disease is neoplasm.